DynaLIFE(DX), Edmonton, Alberta, Canada, T5J 5E2.
Clin Biochem. 2012 Sep;45(13-14):1038-45. doi: 10.1016/j.clinbiochem.2012.06.006. Epub 2012 Jun 14.
Since the incorporation in 1976 of HbA(1c) into a monitoring program of individuals with diabetes, this test has become the gold standard for assessment of glycemic control. Analytical methods have steadily improved in the past two decades, largely through the efforts of the National Glycohemoglobin Standardization program (NGSP). The new definition of HbA(1c) and the introduction of an analytically pure calibrator have increased the possibility for greater improvements in analytical performance. Controversies exist in the reporting of HbA(1c). The use of HbA(1c) has expanded beyond the use solely as a measure of glycemic control into a test for screening and diagnosing diabetes. With improvements in analytical performance, the effects of demographic factors such as age and ethnicity and clinical factors such as iron deficiency have been observed. In this review, the history, formation, analytical methods and parameters that affect HbA(1c) analysis are discussed.
自 1976 年 HbA(1c) 纳入糖尿病患者监测方案以来,该检测已成为评估血糖控制的金标准。过去二十年中,通过国家糖化血红蛋白标准化计划(NGSP)的努力,分析方法得到了稳步改进。HbA(1c) 的新定义和分析纯校准品的引入增加了提高分析性能的可能性。在 HbA(1c) 的报告中存在争议。HbA(1c) 的使用已经超出了作为血糖控制的单一测量指标,扩展到了糖尿病的筛查和诊断。随着分析性能的提高,年龄和种族等人口统计学因素以及缺铁等临床因素的影响已被观察到。在这篇综述中,讨论了 HbA(1c)分析的历史、形成、分析方法和影响参数。